Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |